TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 ID - Torre2015 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2017 DA - 2017// TI - Cancer statistics, 2017 JO - CA Cancer J Clin VL - 67 ID - Siegel2017 ER - TY - STD TI - Wakelee H, Kelly K, Edelman MJ. 50 years of progress in the systemic therapy of non-small cell lung cancer. Am Soc Clin Oncol Educ Book. 2014;(34):177–89. https://doi.org/10.14694/EdBook_AM.2014.34.177. ID - ref3 ER - TY - JOUR AU - Spiro, S. G. AU - Silvestri, G. A. PY - 2005 DA - 2005// TI - One hundred years of lung cancer JO - Am J Respir Crit Care Med VL - 172 ID - Spiro2005 ER - TY - JOUR AU - Stella, G. M. AU - Luisetti, M. AU - Pozzi, E. AU - Comoglio, P. M. PY - 2013 DA - 2013// TI - Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics JO - Lancet Respir Med VL - 1 ID - Stella2013 ER - TY - JOUR AU - Paez, J. G. AU - Janne, P. A. AU - Lee, J. C. PY - 2004 DA - 2004// TI - EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy JO - Science. VL - 304 ID - Paez2004 ER - TY - JOUR AU - Mitsudomi, T. AU - Yatabe, Y. PY - 2007 DA - 2007// TI - Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer JO - Cancer Sci VL - 98 ID - Mitsudomi2007 ER - TY - JOUR AU - Tsao, M. S. AU - Sakurada, A. AU - Cutz, J. C. PY - 2005 DA - 2005// TI - Erlotinib in lung cancer - molecular and clinical predictors of outcome JO - N Engl J Med VL - 353 ID - Tsao2005 ER - TY - JOUR AU - Shaw, A. T. AU - Felip, E. AU - Bauer, T. M. PY - 2017 DA - 2017// TI - Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial JO - Lancet Oncol VL - 18 ID - Shaw2017 ER - TY - JOUR AU - Soda, M. AU - Choi, Y. L. AU - Enomoto, M. PY - 2007 DA - 2007// TI - Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer JO - Nature. VL - 448 ID - Soda2007 ER - TY - JOUR AU - Croegaert, K. AU - Kolesar, J. M. PY - 2015 DA - 2015// TI - Role of anaplastic lymphoma kinase inhibition in the treatment of non-small-cell lung cancer JO - Am J Health Syst Pharm VL - 72 ID - Croegaert2015 ER - TY - JOUR AU - Gerber, D. E. AU - Minna, J. D. PY - 2010 DA - 2010// TI - ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time JO - Cancer Cell VL - 18 ID - Gerber2010 ER - TY - JOUR AU - Botling, J. AU - Edlund, K. AU - Lohr, M. PY - 2013 DA - 2013// TI - Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation JO - Clin Cancer Res VL - 19 ID - Botling2013 ER - TY - JOUR AU - Aibar, S. AU - Abaigar, M. AU - Campos-Laborie, F. J. AU - Sanchez-Santos, J. M. AU - Hernandez-Rivas, J. M. AU - Las Rivas, J. PY - 2016 DA - 2016// TI - Identification of expression patterns in the progression of disease stages by integration of transcriptomic data JO - BMC Bioinformatics VL - 17 ID - Aibar2016 ER - TY - JOUR AU - Kadara, H. AU - Fujimoto, J. AU - Yoo, S. Y. PY - 2014 DA - 2014// TI - Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer JO - J Natl Cancer Inst VL - 106 ID - Kadara2014 ER - TY - JOUR AU - Sanchez-Palencia, A. AU - Gomez-Morales, M. AU - Gomez-Capilla, J. A. PY - 2011 DA - 2011// TI - Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer JO - Int J Cancer VL - 129 ID - Sanchez-Palencia2011 ER - TY - STD TI - Meister M, Belousov A, EC X, et al. Intra-tumor Heterogeneity of Gene Expression Profiles in Early Stage Non-Small Cell Lung Cancer. J Bioinform Res Stud. 2014;1(1):1. https://www.researchgate.net/publication/265858060_Intra-tumor_Heterogeneity_of_Gene_Expression_Profiles_in_Early_Stage_Non-Small_Cell_Lung_Cancer. UR - https://www.researchgate.net/publication/265858060_Intra-tumor_Heterogeneity_of_Gene_Expression_Profiles_in_Early_Stage_Non-Small_Cell_Lung_Cancer ID - ref17 ER - TY - STD TI - Gene Expression Omnibus DataSets. https://www.ncbi.nlm.nih.gov/gds/?term. Accessed 4 May 2018. UR - https://www.ncbi.nlm.nih.gov/gds/?term= ID - ref18 ER - TY - STD TI - GEO2R. https://www.ncbi.nlm.nih.gov/geo/geo2r/. Accessed 4 May 2018. UR - https://www.ncbi.nlm.nih.gov/geo/geo2r/ ID - ref19 ER - TY - STD TI - FunRich software. http://funrich.org/download. Accessed 6 April 2018. UR - http://funrich.org/download ID - ref20 ER - TY - STD TI - Search Tool for the Retrieval of interacting Genes. https://string-db.org/. Accessed 5 May 2018. UR - https://string-db.org/ ID - ref21 ER - TY - STD TI - Cytoscape3.6.0 software. http://www.softpedia.com/get/Science-CAD/Cytoscape.shtml. Accessed 28 May 2018. UR - http://www.softpedia.com/get/Science-CAD/Cytoscape.shtml ID - ref22 ER - TY - STD TI - Kaplan Meier Plotter Survival analysis. http://kmplot.com/analysis/.Accessed 15 June2018. UR - http://kmplot.com/analysis/ ID - ref23 ER - TY - STD TI - National cancer institute https:// www. cancer. gov/ about-nci/ organization/ ccg/ research/ structural-genomics/tcga. Accessed 09 Sep 2019. ID - ref24 ER - TY - STD TI - Gene Expression Profiling Interactive Analysis. http://gepia.cancer-pku.cn/. Accessed 8 May 2018. UR - http://gepia.cancer-pku.cn/ ID - ref25 ER - TY - JOUR AU - Győrffy, B. AU - Surowiak, P. AU - Budczies, J. AU - Lánczky, A. PY - 2013 DA - 2013// TI - Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer JO - PloS one VL - 8 ID - Győrffy2013 ER - TY - STD TI - Human Protein Atlas. https://www.proteinatlas.org/. Accessed 10 Jun 2018. UR - https://www.proteinatlas.org/ ID - ref27 ER - TY - JOUR AU - Bendris, N. AU - Lemmers, B. AU - Blanchard, J. M. PY - 2015 DA - 2015// TI - Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors JO - Cell Cycle VL - 14 ID - Bendris2015 ER - TY - JOUR AU - Vermeulen, K. AU - Bockstaele, D. R. AU - Berneman, Z. N. PY - 2003 DA - 2003// TI - The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer JO - Cell Prolif VL - 36 ID - Vermeulen2003 ER - TY - JOUR AU - Ingham, M. AU - Schwartz, G. K. PY - 2017 DA - 2017// TI - Cell-cycle therapeutics come of age JO - J Clin Oncol VL - 35 ID - Ingham2017 ER - TY - JOUR AU - Kumar, A. AU - Sharma, P. R. AU - Mondhe, D. M. PY - 2017 DA - 2017// TI - Potential anticancer role of colchicine-based derivatives: an overview JO - Anti-Cancer Drugs VL - 28 ID - Kumar2017 ER - TY - JOUR AU - Marzo-Mas, A. AU - Barbier, P. AU - Breuzard, G. PY - 2017 DA - 2017// TI - Interactions of long-chain homologues of colchicine with tubulin JO - Eur J Med Chem VL - 126 ID - Marzo-Mas2017 ER - TY - JOUR AU - Weaver, B. A. PY - 2014 DA - 2014// TI - How Taxol/paclitaxel kills cancer cells JO - Mol Biol Cell VL - 25 ID - Weaver2014 ER - TY - JOUR AU - Zasadil, L. M. AU - Andersen, K. A. AU - Yeum, D. AU - Rocque, G. B. PY - 2014 DA - 2014// TI - Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles JO - Sci Transl Med VL - 6 ID - Zasadil2014 ER - TY - JOUR AU - Xu, B. AU - Xu, T. AU - Liu, H. AU - Min, Q. AU - Wang, S. AU - Song, Q. PY - 2017 DA - 2017// TI - MiR-490-5p suppresses cell proliferation and invasion by targeting BUB1 in hepatocellular carcinoma cells JO - Pharmacology. VL - 100 ID - Xu2017 ER - TY - JOUR AU - Xu, B. AU - Wu, D. P. AU - Xie, R. T. AU - Liu, L. G. AU - Yan, X. B. PY - 2017 DA - 2017// TI - Elevated NDC80 expression is associated with poor prognosis in osteosarcoma patients JO - Eur Rev Med Pharmacol Sci VL - 21 ID - Xu2017 ER - TY - JOUR AU - Ju, L. L. AU - Chen, L. AU - Li, J. H. PY - 2017 DA - 2017// TI - Effect of NDC80 in human hepatocellular carcinoma JO - World J Gastroenterol VL - 23 ID - Ju2017 ER - TY - JOUR AU - Yan, X. AU - Huang, L. AU - Liu, L. AU - Qin, H. AU - Song, Z. PY - 2018 DA - 2018// TI - Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer JO - Cancer Med VL - 7 ID - Yan2018 ER - TY - JOUR AU - Bieche, I. AU - Vacher, S. AU - Lallemand, F. PY - 2011 DA - 2011// TI - Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy JO - Mol Cancer VL - 10 ID - Bieche2011 ER - TY - JOUR AU - Vleugel, M. AU - Hoek, T. A. AU - Tromer, E. PY - 2015 DA - 2015// TI - Dissecting the roles of human BUB1 in the spindle assembly checkpoint JO - J Cell Sci VL - 128 ID - Vleugel2015 ER - TY - JOUR AU - Abal, M. AU - Obrador-Hevia, A. AU - Janssen, K. P. PY - 2007 DA - 2007// TI - APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation JO - Gastroenterology VL - 132 ID - Abal2007 ER - TY - JOUR AU - Ko, Y. H. AU - Roh, J. H. AU - Son, Y. I. PY - 2010 DA - 2010// TI - Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas JO - J Oral Pathol Med VL - 39 ID - Ko2010 ER - TY - JOUR AU - Voer, R. M. AU - Geurts van Kessel, A. AU - Weren, R. D. PY - 2013 DA - 2013// TI - Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer JO - Gastroenterology VL - 145 ID - Voer2013 ER - TY - JOUR AU - Tong, H. AU - Wang, J. AU - Chen, H. AU - Wang, Z. AU - Fan, H. AU - Ni, Z. PY - 2017 DA - 2017// TI - Transcriptomic analysis of gene expression profiles of stomach carcinoma reveal abnormal expression of mitotic components JO - Life Sci VL - 170 ID - Tong2017 ER - TY - JOUR AU - Martel-Frachet, V. AU - Keramidas, M. AU - Nurisso, A. PY - 2015 DA - 2015// TI - IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinoma JO - Oncotarget. VL - 6 ID - Martel-Frachet2015 ER - TY - JOUR AU - Hasanov, E. AU - Chen, G. AU - Chowdhury, P. PY - 2017 DA - 2017// TI - Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL JO - Oncogene. VL - 36 ID - Hasanov2017 ER - TY - JOUR AU - Chen, C. AU - Song, G. AU - Xiang, J. AU - Zhang, H. AU - Zhao, S. AU - Zhan, Y. PY - 2017 DA - 2017// TI - AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma JO - Biochem Biophys Res Commun VL - 486 ID - Chen2017 ER - TY - JOUR AU - Puig-Butille, J. A. AU - Vinyals, A. AU - Ferreres, J. R. PY - 2017 DA - 2017// TI - AURKA overexpression is driven by FOXM1 and MAPK/ERK activation in melanoma cells harboring BRAF or NRAS mutations: impact on melanoma prognosis and therapy JO - J Invest Dermatol VL - 137 ID - Puig-Butille2017 ER - TY - JOUR AU - Song, Z. AU - Ge, Y. AU - Wang, C. PY - 2016 DA - 2016// TI - Challenges and perspectives on the development of small-molecule EGFR inhibitors against T790M-mediated resistance in non-small-cell lung Cancer JO - J Med Chem VL - 59 ID - Song2016 ER - TY - JOUR AU - Chong, C. R. AU - Janne, P. A. PY - 2013 DA - 2013// TI - The quest to overcome resistance to EGFR-targeted therapies in cancer JO - Nat Med VL - 19 ID - Chong2013 ER - TY - JOUR AU - Chen, J. AU - Lu, H. AU - Zhou, W. PY - 2015 DA - 2015// TI - AURKA upregulation plays a role in fibroblast-reduced gefitinib sensitivity in the NSCLC cell line HCC827 JO - Oncol Rep VL - 33 ID - Chen2015 ER - TY - JOUR AU - Astsaturov, I. AU - Ratushny, V. AU - Sukhanova, A. PY - 2010 DA - 2010// TI - Synthetic lethal screen of an EGFR-centered network to improve targeted therapies JO - Sci Signal VL - 3 ID - Astsaturov2010 ER - TY - JOUR AU - Kurup, S. AU - McAllister, B. AU - Liskova, P. PY - 2018 DA - 2018// TI - Design, synthesis and biological activity of N (4)-phenylsubstituted-7H-pyrrolo [2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase a and epidermal growth factor receptor kinase JO - J Enzyme Inhib Med Chem VL - 33 ID - Kurup2018 ER - TY - STD TI - Shah KN, Bhatt R, Rotow J, et al. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nat Med. 2019;25(1):111–8. https://doi.org/10.1038/s41591-018-0264-7. ID - ref54 ER -